TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: <1.00E+4nMAssay Description:Inhibition of MAO-A (unknown origin)More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of MAO-B (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.94E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.94E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.94E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.94E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.26E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.58E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.51E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 3.10E+4nMAssay Description:Inhibition of CYP2B6 (unknown origin)More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.16E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.16E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.16E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.98E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <5.01E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 5.01E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: <6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair
TargetSodium channel protein type 3 subunit alpha(Homo sapiens (Human))
Convergence Pharmaceuticals
Curated by ChEMBL
Convergence Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.31E+4nMAssay Description:Inhibition of Nav1.3 (unknown origin) expressed in HEK293 cells assessed as inhibition of sodium current incubated for 3 to 3.5 mins by electrophysio...More data for this Ligand-Target Pair